Advanced search
Publication Cover
HIV Clinical Trials Volume 11, 2010 - Issue 2
Submit an article Journal homepage
41
Views
15
CrossRef citations to date
0
Altmetric
Brief report

Twelve-Year Experience of Nevirapine Use: Benefits and Convenience for Long-Term Management in a French Cohort of HIV-1–Infected Patients

V. ReliquetInfectious Diseases Department University Hospital, Nantes, FranceCorrespondence[email protected]
,
C. AllavenaInfectious Diseases Department University Hospital, Nantes, France
,
P. Morineau-Le HoussineInfectious Diseases Department University Hospital, Nantes, France
,
O. MounouryInfectious Diseases Department University Hospital, Nantes, France
&
F. RaffiInfectious Diseases Department University Hospital, Nantes, France
Pages 110-117 | Published online: 06 Jan 2015

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jean-Jacques Parienti & Gilles Peytavin. (2011) Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation. Expert Opinion on Drug Metabolism & Toxicology 7:4, pages 495-503.
Read now

Articles from other publishers (14)

Suzana Mustafa, Mahiran Mustafa & Wan Nazirah Wan Yusuf. (2023) Methadone Reduced Nevirapine Pharmacokinetic Parameters in People Living With HIV in Malaysia. Malaysian Journal of Medicine and Health Sciences 19:3, pages 247-253.
Crossref
Ana M. Benedicto, Isabel Fuster-Martínez, Joan Tosca, Juan V. Esplugues, Ana Blas-García & Nadezda Apostolova. (2021) NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. Cells 10:7, pages 1687.
Crossref
C. R. Kahlert, M. Cipriani & P. Vernazza. (2020) Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study. PLOS ONE 15:9, pages e0237770.
Crossref
Naho Kuroishi, Asuka Watananbe, Ryuta Sakuma, Daniel J. Ruzicka & Mitsuyoshi Hara. (2019) Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance. PLOS ONE 14:1, pages e0210384.
Crossref
Andrea Giacomelli, Agostino Riva, Felicia Stefania Falvella, Maria Letizia Oreni, Dario Cattaneo, Stefania Cheli, Giulia Renisi, Valentina Di Cristo, Angelica Lupo, Emilio Clementi, Stefano Rusconi, Massimo Galli & Anna Lisa Ridolfo. (2018) Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infectious Diseases 18:1.
Crossref
Roberto Ravasio, Mauro Maresca, Barbara Busà & Benedetto Maurizio Celesia. (2017) Impatto Economico Dei Regimi Semplificati a Base di Raltegravir Nel Trattamento di Mantenimento Dei Pazienti HIV-1 Infetti in Soppressione Virologica. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 4:1, pages grhta.5000266.
Crossref
Paul de Boissieu, Moustapha Dramé, François Raffi, André Cabie, Isabelle Poizot-Martin, Laurent Cotte, Rodolphe Garraffo, Pierre Delobel, Thomas Huleux, David Rey & Firouzé Bani-Sadr. (2016) Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study. Medicine 95:37, pages e4890.
Crossref
Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia & Massimiliano Lanzafame. (2016) Economic Evaluation of Nevirapine plus Raltegravir as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1 Infected Patients. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 3:2, pages GRHTA.5000217.
Crossref
Katherine J Lepik, Benita Yip, Rachel A McGovern, Erin Ding, Adriana Nohpal, Birgit E Watson, Junine Toy, Linda Akagi, P Richard Harrigan, David M Moore, Robert S Hogg, Julio SG Montaner & Rolando Barrios. (2014) Post-Marketing Experience with Nevirapine Extended Release (XR) Tablets: Effectiveness and Tolerability in a Population-Based Cohort in British Columbia, Canada. Antiviral Therapy 20:7, pages 721-730.
Crossref
Véronique Reliquet, Catherine Chirouze, Clotilde Allavena, Patrice Muret, Gilles Peytavin, Elisabeth André-Garnier, Dominique Bettinger, Virginie Ferré, Bruno Hoen & François Raffi. (2014) Nevirapine–Raltegravir Combination, An Nrti and Pi/R Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients. Antiviral Therapy 19:1, pages 117-123.
Crossref
Laveeza Bhatti & Jay Gladstein. (2012) Once-Daily Nevirapine XR. Journal of the International Association of Physicians in AIDS Care 11:6, pages 369-373.
Crossref
BJ Welzen, T Mudrikova, JE Arends & AIM Hoepelman. (2012) No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients. HIV Medicine 13:7, pages 448-452.
Crossref
Judith Neumaier. (2012) Lebenslange Therapie muss gut verträglich sein. MMW - Fortschritte der Medizin 154:23-24, pages 52-52.
Crossref
Brian S. Eley & Tammy Meyers. (2011) Antiretroviral Therapy for Children in Resource-Limited Settings. Pediatric Drugs 13:5, pages 303-316.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.